Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Feb 8, 2022
CEPI, Shanghai Zerun Biotech and Walvax Biotech expand collaboration to develop COVID-19 multi-variant vaccine
Learn More
Sep 26, 2023
Walvax and RNAcure Announce Safety, Immunogenicity and Efficacy Data from Phase 3b Clinical Study of RQ3013 (SARS-CoV-2 Variants mRNA Vaccine) Published in eClinicalMedicine
Learn More
May 19, 2023
Walvax’s PCV13-TT Receives Endorsement from the Pediatric Infectious Disease Society of Thailand
Learn More